0.730
-0.01 (-1.35%)
| Penutupan Terdahulu | 0.740 |
| Buka | 0.740 |
| Jumlah Dagangan | 3,306,000 |
| Purata Dagangan (3B) | 8,068,586 |
| Modal Pasaran | 7,016,082,944 |
| Harga / Pendapatan (P/E Ke hadapan) | 24.21 |
| Harga / Jualan (P/S) | 1.31 |
| Harga / Buku (P/B) | 1.88 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 18 Mar 2025 |
| Margin Keuntungan | -2.29% |
| Margin Operasi (TTM) | -2.60% |
| EPS Cair (TTM) | -0.010 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 5.20% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -97.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 173.70% |
| Nisbah Semasa (MRQ) | 1.28 |
| Aliran Tunai Operasi (OCF TTM) | 353.53 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 87.52 M |
| Pulangan Atas Aset (ROA TTM) | 0.44% |
| Pulangan Atas Ekuiti (ROE TTM) | -3.29% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (HK) | Bercampur | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | CKLIFE SCIENCES | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 1.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -4.0 |
| Purata | -0.63 |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| CKLIFE SCIENCES | 7 B | - | - | 1.88 |
| CSTONE PHARMA-B | 14 B | - | - | 27.87 |
| VIVA BIOTECH | 4 B | - | 28.57 | 0.940 |
| ANTENGENE-B | 3 B | - | - | 2.84 |
| SINOMAB BIO-B | 2 B | - | - | 4.23 |
| IMMUNOTECH-B | 2 B | - | - | 20.15 |
|
CK Life Sciences International Holdings Inc is a biotechnology company engaged in the research & development, commercialization, and sale of health and agricultural-related products. Products developed by CK Life Sciences are categorized into the areas of human health and environmental sustainability. The operating segments of the company are Agriculture-related and Health. The company derives maximum revenue from the health segment. The overall product portfolio of the company involves a presence that spans North America and the Asia Pacific. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 74.98% |
| % Dimiliki oleh Institusi | 0.31% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |